Literature DB >> 19590719

Factors associated with HPV persistence after conization in patients with negative margins.

Kyehyun Nam1, Sooho Chung, Jeongsig Kim, Seob Jeon, Donghan Bae.   

Abstract

OBJECTIVE: The clearance rate of human papillomavirus (HPV) after conization is generally high, although some HPV infections persist. We investigated the factors that affect the clearance of HPV after conization in patients with negative margins.
METHODS: We retrospectively analyzed 77 patients (mean age 39.9 years, range 25 to 51 years) with CIN 2/3 who underwent loop electrosurgical excision procedure (LEEP) conization with negative margins. All patients had a Pap smear and high-risk (HR) HPV testing using Hybrid Capture II system and HPV DNA chip before conization. We used>/=1 relative light units (RLUs) as the cutoff for persistence of HPV after conization.
RESULTS: High-risk HPV was detected in 73 of 77 (94.8%) patients before conization. At the 6-months follow-up, the high-risk HPV was eliminated in 60 of 73 (82.2%) patients. The HPV persistence rate after conization was 17.8% (13/73). Univariate analysis showed that persistent HPV infection after conization with negative margins was more likely to occur when the pretreatment viral load was high (RLU/positive control >100 (p=0.027) and the HPV was type 16 (p=0.021). Logistic regression analysis showed that preoperative HPV type 16 infection was the only significant independent factor (p=0.021) for HPV persistence out of age, cytology, punch biopsy histology, HPV viral load, and conization histology.
CONCLUSION: Conization effectively removes HR-HPV infection. HPV type 16 infection before conization was significantly related to HR-HPV persistence after conization with negative margins. Therefore, patients with HPV 16 infection before conization need to be followed closely.

Entities:  

Keywords:  Conization; HPV type 16; Negative margins; Persistent HPV infection

Year:  2009        PMID: 19590719      PMCID: PMC2705006          DOI: 10.3802/jgo.2009.20.2.91

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  24 in total

Review 1.  Natural history of cervical neoplasia: defining progression and its consequence.

Authors:  A P Pinto; C P Crum
Journal:  Clin Obstet Gynecol       Date:  2000-06       Impact factor: 2.190

Review 2.  Management of cervical premalignant lesions.

Authors:  B G Lindeque
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2005-03-26       Impact factor: 5.237

3.  Treatment outcomes for squamous intraepithelial lesions.

Authors:  J Nuovo; J Melnikow; A R Willan; B K Chan
Journal:  Int J Gynaecol Obstet       Date:  2000-01       Impact factor: 3.561

Review 4.  Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.

Authors:  William Patrick Soutter; Peter Sasieni; Theo Panoskaltsis
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

5.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Authors:  E L Franco; L L Villa; J P Sobrinho; J M Prado; M C Rousseau; M Désy; T E Rohan
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

6.  Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Authors:  Véronique Dalstein; Didier Riethmuller; Jean-Luc Prétet; Karine Le Bail Carval; Jean-Loup Sautière; Jean-Pierre Carbillet; Bernadette Kantelip; Jean-Patrick Schaal; Christiane Mougin
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

7.  Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis.

Authors:  Sadaf Ghaem-Maghami; Shlomi Sagi; Gulnaz Majeed; William P Soutter
Journal:  Lancet Oncol       Date:  2007-10-24       Impact factor: 41.316

8.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Authors:  Margaret R E McCredie; Katrina J Sharples; Charlotte Paul; Judith Baranyai; Gabriele Medley; Ronald W Jones; David C G Skegg
Journal:  Lancet Oncol       Date:  2008-04-11       Impact factor: 41.316

9.  Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure.

Authors:  J H Bae; C J Kim; T C Park; S E Namkoong; J S Park
Journal:  Int J Gynecol Cancer       Date:  2007-04-18       Impact factor: 3.437

10.  Invasive cancer after treatment of cervical intraepithelial neoplasia.

Authors:  W P Soutter
Journal:  Ann Acad Med Singapore       Date:  1998-09       Impact factor: 2.473

View more
  13 in total

1.  Application value of different transformation zone types and its genetic relationship with high-risk HPV type in diagnosis and therapy of cervical disease.

Authors:  Yan Chen; Jia-De Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

3.  Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia.

Authors:  Aeli Ryu; Kyehyun Nam; Sooho Chung; Jeongsik Kim; Haehyeog Lee; Eunsuk Koh; Donghan Bae
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

Review 4.  Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.

Authors:  Sarah R Hoffman; Tam Le; Alexandre Lockhart; Ayodeji Sanusi; Leila Dal Santo; Meagan Davis; Dana A McKinney; Meagan Brown; Charles Poole; Corinne Willame; Jennifer S Smith
Journal:  Int J Cancer       Date:  2017-02-27       Impact factor: 7.396

5.  Distribution of HPV genotypes in Shanghai women.

Authors:  Suman Singh; Qian Zhou; Yunyun Yu; Xianghong Xu; Xiaojie Huang; Junwei Zhao; Lingfei Han; Kai Wang; Jing Sun; Fang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Association Between Positive Human Papillomavirus Status After Conization and Disease Recurrence in Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Masaki Kamio; Shintaro Yanazume; Shinichi Togami; Hiroaki Kobayashi
Journal:  J Obstet Gynaecol India       Date:  2020-09-10

7.  The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment.

Authors:  Antonio Frega; Francesco Sopracordevole; Paolo Scirpa; Alberto Biamonti; Laura Lorenzon; Simona Scarani; Luana De Sanctis; Arianna Pacchiarotti; Massimo Moscarini; Deborah French
Journal:  Med Sci Monit       Date:  2011-09

Review 8.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.

Authors:  Chichao Xia; Sile Li; Teng Long; Zigui Chen; Paul K S Chan; Siaw Shi Boon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

9.  Early human papillomavirus testing predicts residual/recurrent disease after LEEP.

Authors:  Aeli Ryu; Kyehyun Nam; Jeongja Kwak; Jeongsig Kim; Seob Jeon
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

10.  Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study.

Authors:  Laurențiu Pirtea; Dorin Grigoraş; Petru Matusz; Marilena Pirtea; Lavinia Moleriu; Anca Tudor; Răzvan Ilina; Cristina Secoşan; Florin Horhat; Octavian Mazilu
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-12       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.